Medical ID use by international patients with Aspirin-Exacerbated Respiratory Disease
Abstract Background Patients widely use medical identification (ID) to indicate their food and drug allergies, and chronic medical conditions. One chronic condition for which patients are recommended to use a form of medical ID is Aspirin-Exacerbated Respiratory Disease (AERD), a disease characteriz...
Main Authors: | Mohammed Alqabasani, Andrea Lasso, Shaun Kilty |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-023-00766-7 |
Similar Items
-
Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial
by: Leigh J. Sowerby, et al.
Published: (2021-04-01) -
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics
by: Busse WW, et al.
Published: (2023-04-01) -
Aspirin desensitization in nonsteroidal anti-inflammatory exacerbated respiratory disease: The first prospective cohort in Chile
by: María Josefina Siña, et al.
Published: (2023-02-01) -
Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD
by: Fatma Merve Tepetam, MD, et al.
Published: (2023-09-01) -
Samter’s Triad: pathogenesis, clinical picture, diagnosis, comparison of biological and surgical treatment and the role of aspirin desensitisation
by: Bianka Nowińska, et al.
Published: (2022-12-01)